[NBIX] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
07-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY- 114.81%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 1,133,500 1,045,900 788,100 451,240 161,626 15,000 19,769 96.24%
PBT 101,400 106,700 46,500 21,841 -142,542 -141,090 -88,929 -
Tax 11,800 -300,600 9,500 730 17,103 -7,722 -6,271 -
NP 89,600 407,300 37,000 21,111 -142,542 -141,090 -88,929 -
Tax Rate -11.64% 281.72% -20.43% -3.34% - - - -
Total Cost 1,043,900 638,600 751,100 430,129 304,168 156,090 108,698 45.74%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 7.90 38.94 4.69 4.68 -88.19 -940.60 -449.84 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS 0.95 4.37 0.40 0.22 -1.62 -1.63 -1.05 -
EPS Diluted 0.92 4.16 0.39 0.22 -1.62 -1.63 -1.05 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.